Nonalcoholic Fatty Liver Disease Leukopak

LeukoCore Nonalcoholic Fatty Liver Disease Leukopak for Immunology Research

LeukoCore Nonalcoholic Fatty Liver Disease Leukopak biospecimens are collected from donors clinically diagnosed with NAFLD through IRB-approved apheresis procedures. Each leukopak contains large quantities of peripheral blood mononuclear cells (PBMCs), making it ideal for immune profiling, cytokine analysis, and drug development research related to NAFLD-associated inflammation and immune dysregulation.

Product Features

  • Research Use Only (RUO) human leukopaks
  • Clinically confirmed NAFLD donors
  • High cell yield for large-scale studies
  • Processed and shipped within 24 hours of collection
  • Fresh or cryopreserved options available
  • IRB-approved and ethically sourced
  • Infectious disease testing
  • HLA-A typing
  • Screen donors with LeukoLot™ (https://sanguinebio.com/bulk-pbmcs/)

De-identified Donor Data

  • Verified NAFLD diagnosis from healthcare providers
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported medication history and allergies
  • Relevant clinical data NAFLD

Applications

  • Immune cell characterization in NAFLD
  • Therapeutic development and screening
  • Cell-based assays and cytokine profiling
  • Multi-omics studies single-cell sequencing

Compliance and Quality Assurance

  • Collected under IRB oversight with donor e-consent (21 CFR Part 11 compliant)
  • HIPAA-compliant handling of donor information
  • Rigorous donor screening and documentation

Ordering & Customization

Nonalcoholic Fatty Liver Disease Leukopak samples are available fresh or cryopreserved. For international shipping or regulatory documentation, please contact learnmore@sanguinebio.com to confirm regional compliance and shipping availability.

Protocols & Documentation

  • Leukopak Cryopreservation

    Standard operating procedure for cryopreserving leukopak units with controlled freezing and post-thaw viability targets.

    Download
  • Leukopak Thawing

    Validated thawing workflow for cryopreserved leukopaks to maximize recovery while maintaining sterility and chain of custody.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Leukopak

Frequently Asked Questions

Showing 13–24 of 24 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Unique donors can be specified.

International shipping is available. For more information and documentation requirements, please contact learnmore@sanguinebio.com.

YES – We offer cryopreservation of leukopaks and PBMC processing, aliquoting, and cryopreservation.

YES – We offer full and half size leukopaks both fresh and cryopreserved.

1 2
×

Ask a Question

Need a custom Leukopak cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information